Once again, we observed that the highest number of patients spending ≥ 10% of their family income on both therapeutic treatment (27%) and non-therapeutic treatment (11%) were from the lower SES with highly significant statistical p-values (chi-square) of 0.000 and 0.024 respectively.
← all excerpts
Prescription cost analysis and economic impact of drug treatment in patients with chronic illness, attending the medicine out-patient department in a tertiary care hospital at South Delhi.
1
—
—